Page last updated: 2024-11-11

2-deoxyribose 1-phosphate, (alpha-d-erythro)-isomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5460448
CHEBI ID11563
SCHEMBL ID4623877
MeSH IDM0319185

Synonyms (11)

Synonym
CHEBI:11563 ,
2-deoxy-alpha-d-erythro-pentofuranose 1-(dihydrogen phosphate)
2-deoxy-1-o-phosphono-alpha-d-erythro-pentofuranose
C00672
2-deoxyribose 1-phosphate
SCHEMBL4623877
2-deoxy-alpha-d-ribose-1-phosphate
Q27108892
alpha-d-erythro-pentofuranose, 2-deoxy-, 1-(dihydrogen phosphate)
17039-17-7
DTXSID801181425
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
2-deoxy-D-ribofuranose 1-phosphateA 2-deoxyribose 1-phosphate with D-ribofuranose as the sugar. An intermediate in the metabolism of pyrimidine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (12)

PathwayProteinsCompounds
Purine nucleotides and Nucleosides metabolism ( Purine nucleotides and Nucleosides metabolism )10577
Deoxy-adenosine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Adenine ( Purine nucleotides and Nucleosides metabolism )14
Deoxy-inosine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Hypoxanthine ( Purine nucleotides and Nucleosides metabolism )14
Deoxy-guanosine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Guanine ( Purine nucleotides and Nucleosides metabolism )14
Pyrimidine Nucleotides and Nucleosides metabolism ( Pyrimidine Nucleotides and Nucleosides metabolism )4549
Deoxy-uridine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Uracil ( Pyrimidine Nucleotides and Nucleosides metabolism )14
Thymidine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Thymine ( Pyrimidine Nucleotides and Nucleosides metabolism )14
superpathway of ribose and deoxyribose phosphate degradation024
(deoxy)ribose phosphate degradation018
salvage pathways of adenine, hypoxanthine, and their nucleosides023
purine and pyrimidine metabolism032
salvage pathways of guanine, xanthine, and their nucleosides017

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (35.48)18.7374
1990's3 (9.68)18.2507
2000's9 (29.03)29.6817
2010's7 (22.58)24.3611
2020's1 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.16 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]